| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
* From the Department of Anesthesiology, Kangnam Saint Mary's Hospital, 505 Banpo-dong, Seocho-gu, Seoul, Korea and the Puget Sound Veterans Affairs Medical Center and the University of Washington School of Medicine, Seattle, Washington.
Address correspondence to: Dr. Jaimin Lee, 137-040, Department of Anesthesiology, Kangnam Saint Mary's Hospital, 505 Banpo-dong, Seocho-gu, Seoul, Korea. Phone: 82-2-590-1545; Fax: 82-2-537-1951; E-mail: jmlee{at}cmc.cuk.ac.kr
Purpose: To determine whether epidural naloxone preserved analgesia while minimizing side effects caused by epidural morphine.
Methods: Eighty patients undergoing combined epidural and general anesthesia for hysterectomy were randomly assigned to one of four groups. All received 2 mg epidural morphine bolus one hour before the end of surgery and a continuous epidural infusion was started containing 4 mg morphine in 100 ml bupivacaine 0.125% with either no naloxone (Group 1, n=20), 0.083 µgkg1hr1 of naloxone (Group 2, n=20), 0.125 µgkg1hr1 of naloxone (Group 3, n=20) or 0.167 µgkg1hr1 of naloxone (Group 4, n=20). Analgesia and side effects were evaluated by blinded observers.
Results: The combination of epidural morphine and bupivacaine provided good analgesia. Eight hours after the end of surgery, the pain score in the group receiving the highest dose of naloxone was lower than in the control group (VAS 1.2 vs 2.0, P < 0.05) but there was less pruritus in the high-dose naloxone group (itching score 1.3 vs 1.9, P < 0.05). Pain scores were no different in any of the naloxone groups from the control group. Itching was less in both of the higher dose naloxone groups (P < 0.05 at 8, 16, and 32 hours). The incidence of vomiting in the control group was 40% vs 5% for high dose naloxone group (P < 0.05).
Conclusions: Epidural naloxone reduced morphine-induced side effects in dose-dependent fashion without reversal of the analgesic effect.
This article has been cited by other articles:
![]() |
M. K. Kim, S. B. Nam, M. J. Cho, and Y.-S. Shin Epidural naloxone reduces postoperative nausea and vomiting in patients receiving epidural sufentanil for postoperative analgesia Br. J. Anaesth., August 1, 2007; 99(2): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Kim, J. Lee, and J. H. Choi Optimal dose range of epidural naloxone to reduce nausea in patients receiving epidural morphine Can J Anesth, December 1, 2004; 51(10): 1048 - 1049. [Full Text] [PDF] |
||||
![]() |
J.-I. Tzeng, K.-S. Chu, S.-T. Ho, K.-I Cheng, K.-S. Liu, and J.-J. Wang Prophylactic iv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control: [L'administration prophylactique d'ondansetron iv reduit les nausees, les vomissements et le prurit qui suivent l'administration peridurale de morphine analgesique postoperatoire] Can J Anesth, December 1, 2003; 50(10): 1023 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, J. Y. Shim, J. H. Choi, E. S. Kim, O. K. Kwon, D. E. Moon, J. H. Choi, and M. J. Bishop Epidural naloxone reduces intestinal hypomotility but not analgesia of epidural morphine Can J Anesth, January 1, 2001; 48(1): 54 - 58. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |